Ponatinib/blinatumomab for relapsed Philadelphia chromosome-positive leukemia as a bridge to allogeneic transplantation

We report three cases of ponatinib/blinatumomab (Pona/BLIN) combination therapy as a bridge to allogeneic hematopoietic cell transplantation (allo-HCT) in patients with relapsed/refractory Philadelphia chromosome-positive acute lymphoblastic leukemia (r/r-Ph + ALL) or lymphoid chronic myeloid leukem...

Descripción completa

Detalles Bibliográficos

Autores principales:	Yasutaka Sadaga, Daisuke Watanabe, Yuho Najima, Daichi Sadato, Chizuko Hirama, Kana Kato, Kaori Kondo, Chika Kato, Satoshi Sakai, Yasuhiro Kambara, Masashi Shimabukuro, Atsushi Jinguji, Naoki Shingai, Kyoko Haraguchi, Takashi Toya, Hiroaki Shimizu, Takeshi Kobayashi, Yoshiki Okuyama, Yuka Harada, Daisuke Mizuchi, Noriko Doki
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	Taylor & Francis Group 2025-12-01
Colección:	Hematology
Materias:	Ponatinib blinatumomab Philadelphia chromosome positive acute lymphoblastic leukemia chronic myeloid leukemia allogeneic hematopoietic stem cell transplantation
Acceso en línea:	https://www.tandfonline.com/doi/10.1080/16078454.2025.2539550
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!